Robert S. Fenning

650 total citations
13 papers, 503 citations indexed

About

Robert S. Fenning is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert S. Fenning has authored 13 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert S. Fenning's work include Coronary Interventions and Diagnostics (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Cardiac Imaging and Diagnostics (2 papers). Robert S. Fenning is often cited by papers focused on Coronary Interventions and Diagnostics (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Cardiac Imaging and Diagnostics (2 papers). Robert S. Fenning collaborates with scholars based in United States, United Kingdom and India. Robert S. Fenning's co-authors include Robert L. Wilensky, Damir Hamamdzic, Emile R. Mohler, Mark Burgert, Colin H. Macphee, Bryan E. Hoffman, Ping Zhang, Jisheng Yang, James G. Bollinger and Rosanna C. Mirabile and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Robert S. Fenning

13 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Fenning United States 8 200 190 103 96 80 13 503
Suvi E. Heinonen Finland 12 221 1.1× 162 0.9× 77 0.7× 153 1.6× 59 0.7× 24 559
Xinyang Hu China 11 260 1.3× 105 0.6× 90 0.9× 90 0.9× 59 0.7× 34 564
Minjia Zhu China 7 299 1.5× 198 1.0× 113 1.1× 38 0.4× 47 0.6× 11 569
Alicia Zukas United States 9 170 0.8× 107 0.6× 99 1.0× 92 1.0× 40 0.5× 21 687
Anna Helgadóttir Iceland 10 241 1.2× 123 0.6× 64 0.6× 85 0.9× 70 0.9× 16 582
Melissa Bevard United States 6 259 1.3× 89 0.5× 108 1.0× 233 2.4× 117 1.5× 6 690
Nicole E. Hastings United States 7 274 1.4× 104 0.5× 80 0.8× 146 1.5× 67 0.8× 7 581
Kaida Ji China 11 170 0.8× 86 0.5× 87 0.8× 60 0.6× 35 0.4× 15 429
Robel Getachew Australia 16 447 2.2× 79 0.4× 82 0.8× 128 1.3× 40 0.5× 26 736

Countries citing papers authored by Robert S. Fenning

Since Specialization
Citations

This map shows the geographic impact of Robert S. Fenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Fenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Fenning more than expected).

Fields of papers citing papers by Robert S. Fenning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Fenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Fenning. The network helps show where Robert S. Fenning may publish in the future.

Co-authorship network of co-authors of Robert S. Fenning

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Fenning. A scholar is included among the top collaborators of Robert S. Fenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Fenning. Robert S. Fenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Saybolt, Matthew D., Scott Lilly, Dhavalkumar Patel, et al.. (2016). The vulnerable artery: early and rapid deposition of lipid in coronary arteries is associated with subsequent development of thin-cap fibroatheromas. EuroIntervention. 11(14). e1612–e1618. 9 indexed citations
2.
Fenning, Robert S., Mark Burgert, Damir Hamamdzic, et al.. (2015). Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein‐Associated Phospholipase A 2. Journal of the American Heart Association. 4(2). 18 indexed citations
3.
Fenning, Robert S. & Robert L. Wilensky. (2014). New Insights into the Vulnerable Plaque from Imaging Studies. Current Atherosclerosis Reports. 16(3). 397–397. 6 indexed citations
4.
Kuppachi, Sarat, Harris Naina, Sally Self, & Robert S. Fenning. (2013). Plasmacytoma-Like Post-Transplantation Lymphoproliferative Disorder Confined to the Renal Allograft: A Case Report. Transplantation Proceedings. 45(7). 2791–2794. 7 indexed citations
5.
Patel, Dhavalkumar, et al.. (2013). Subsequent Development of Fibroatheromas With Inflamed Fibrous Caps Can Be Predicted by Intracoronary Near Infrared Spectroscopy. Arteriosclerosis Thrombosis and Vascular Biology. 33(2). 347–353. 27 indexed citations
6.
Qamar, Arman, Robert S. Fenning, Atif Qasim, et al.. (2012). Abstract 17995: Plasma Fibroblast Growth Factor-21 Levels are Positively Associated with Metabolic Syndrome, Insulin Resistance and Systemic Inflammation. 126. 1 indexed citations
7.
Heuer, Gregory G., Robert S. Fenning, Todd J. Kilbaugh, et al.. (2011). Pulmonary edema and cardiac dysfunction after resection of a fourth ventricle tumor in a toddler: case report. Child s Nervous System. 27(11). 2005–2009. 1 indexed citations
8.
Orlova, Ksenia, Whitney E. Parker, Gregory G. Heuer, et al.. (2010). STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. Journal of Clinical Investigation. 120(5). 1591–1602. 85 indexed citations
9.
Hamamdzic, Damir, Robert S. Fenning, Dhavalkumar Patel, et al.. (2010). Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. American Journal of Physiology-Heart and Circulatory Physiology. 299(3). H699–H706. 38 indexed citations
10.
Wilensky, Robert L., Yi Shi, Emile R. Mohler, et al.. (2008). Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nature Medicine. 14(10). 1059–1066. 294 indexed citations
11.
Gudena, Vinay, et al.. (2008). Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review. Cancer Biology & Therapy. 7(6). 810–813. 5 indexed citations
12.
Hayslip, John & Robert S. Fenning. (2007). Safe Administration of Iodine-131 Tositumomab After Repeated Infusion-Related Reactions to Rituximab. The Oncologist. 12(3). 338–340. 3 indexed citations
13.
Yen, Andrew, Robert S. Fenning, Roshantha A.S. Chandraratna, Patricia Walker, & Susi Varvayanis. (2004). A Retinoic Acid Receptor β/γ-Selective Prodrug (tazarotene) Plus a Retinoid X Receptor Ligand Induces Extracellular Signal-Regulated Kinase Activation, Retinoblastoma Hypophosphorylation, G0 Arrest, and Cell Differentiation. Molecular Pharmacology. 66(6). 1727–1737. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026